Improved binding activity of antibodies against major histocompatibility complex class I chain-related gene A by phage display technology for cancer-targeted therapy.
about
Doxorubicin-conjugated bacteriophages carrying anti-MHC class I chain-related A for targeted cancer therapy in vitro.The influence of antibody fragment format on phage display based affinity maturation of IgG.Substitution of Heavy Complementarity Determining Region 3 (CDR-H3) Residues Can Synergistically Enhance Functional Activity of Antibody and Its Binding Affinity to HER2 Antigen.
P2860
Improved binding activity of antibodies against major histocompatibility complex class I chain-related gene A by phage display technology for cancer-targeted therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Improved binding activity of a ...... y for cancer-targeted therapy.
@ast
Improved binding activity of a ...... y for cancer-targeted therapy.
@en
type
label
Improved binding activity of a ...... y for cancer-targeted therapy.
@ast
Improved binding activity of a ...... y for cancer-targeted therapy.
@en
prefLabel
Improved binding activity of a ...... y for cancer-targeted therapy.
@ast
Improved binding activity of a ...... y for cancer-targeted therapy.
@en
P2093
P2860
P356
P1476
Improved binding activity of a ...... y for cancer-targeted therapy.
@en
P2093
Achara Phumyen
Amonrat Jumnainsong
Chanvit Leelayuwat
P2860
P304
P356
10.1155/2012/597647
P577
2012-11-21T00:00:00Z